Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Recruiting3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT07154511Phase 1/2Recruiting
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Parkinson DiseaseParkinson Disease Dementia
PrincipalinvestigatorStart date: 2025-11-07
NCT07642908Recruiting
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
Parkinson Disease
PrincipalinvestigatorStart date: 2025-09-18
NCT05962476Not ApplicableTerminated
Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease
Parkinson Disease
PrincipalinvestigatorStart date: 2023-08-09
NCT07863180Phase 1/2Recruiting
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy(PSP)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07154511Phase 1/2PrincipalInvestigator

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Parkinson DiseaseParkinson Disease Dementia
Recruiting
NCT07642908PrincipalInvestigator

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Parkinson Disease
Recruiting
NCT05962476Not ApplicablePrincipalInvestigator

Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease

Parkinson Disease
Terminated
NCT07863180Phase 1/2PrincipalInvestigator

Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial

Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy(PSP)
Recruiting

All 4 trials loaded